Corcept Therapeutics Announces Second Quarter 2013 Financial Results and Corporate Update
August 08, 2013 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Aug 8, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics to Announce Second Quarter 2013 Financial Results and Host Conference Call
August 01, 2013 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Aug 1, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter 2013 financial results on August 8, 2013. The Company...
Corcept Therapeutics Announces Partnership With Idis for Global Access to Korlym(R)
July 24, 2013 09:00 ET
|
Corcept Therapeutics
PRINCETON, NJ and MENLO PARK, CA--(Marketwired - Jul 24, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that Korlym® (mifepristone) 300 mg Tablets is available to...
Corcept Therapeutics Announces First Quarter 2013 Financial Results
May 02, 2013 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - May 2, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics to Announce First Quarter 2013 Financial Results and Host Conference Call
April 26, 2013 09:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Apr 26, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter 2013 financial results on May 2, 2013. The Company will...
Corcept Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results
March 07, 2013 17:01 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - Mar 7, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics Announces Fourth Quarter and Full Year Revenue and Corporate Update
February 12, 2013 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - Feb 12, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs...
Corcept Therapeutics Announces Third Quarter Results and Corporate Update
October 31, 2012 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - Oct 31, 2012) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
October 15, 2012 09:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - Oct 15, 2012) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics Announces $30 Million Synthetic, Capped Royalty Transaction; Terminates Committed Equity Financing Facility
August 07, 2012 08:35 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - Aug 7, 2012) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...